Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1991 Aug;214(2):131–140. doi: 10.1097/00000658-199108000-00007

Metabolic consequences of (regional) total pancreatectomy.

C M Dresler 1, J G Fortner 1, K McDermott 1, D R Bajorunas 1
PMCID: PMC1358512  PMID: 1867520

Abstract

Little information has been reported on the metabolic characteristics of the totally pancreatectomized patient or the efficacy of medical management after radical pancreatic surgery. The prospective evaluation of 49 such patients, with 31% followed for 48 or more months, forms the basis of this report. The major immediate postoperative challenge is control of diarrhea and weight stabilization. Chronically patients have an increased daily caloric requirement (mean +/- SE, 56 +/- 1 kcal/kg), not wholly explained by moderate steatorrhea (fecal fat excretion, 16% +/- 2% of unrestricted fat intake). Despite persistent malabsorption, deficiencies in fat-soluble vitamin, magnesium, and trace element serum levels can be prevented in most patients. Pancreatogenic diabetes is characterized by (1) absence of the major glucoregulatory hormones insulin and glucagon, (2) instability, and (3) frequent hypoglycemia, with the latter parameters improving with rigorous home glucose monitoring. No patient has developed clinically overt diabetic micro- or macrovascular disease. Performance status in long-term survivors has been reasonable. However adverse chronic sequelae of the operation occur and include an unusual frequency of liver disease, characterized by accelerated fatty infiltration, and osteopenia, with an 18% reduction in radial bone mineral content noted in pancreatectomized patients studied more than 5 years after surgery.

Full text

PDF
131

Images in this article

136Fig. 3.
on p.136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham E. C., Huff T. A., Cope N. D., Wilson J. B., Jr, Bransome E. D., Jr, Huisman T. H. Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus. Diabetes. 1978 Sep;27(9):931–937. doi: 10.2337/diab.27.9.931. [DOI] [PubMed] [Google Scholar]
  2. Bajorunas D. R., Dresler C. M., Horowitz G. D., McDermott K., Jeevanandam M., Fortner J. G., Brennan M. F. Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance. Diabetes. 1986 May;35(5):556–562. doi: 10.2337/diab.35.5.556. [DOI] [PubMed] [Google Scholar]
  3. Bajorunas D. R., Fortner J. G., Jaspan J. B. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose. Diabetes. 1986 Aug;35(8):886–893. doi: 10.2337/diab.35.8.886. [DOI] [PubMed] [Google Scholar]
  4. Bajorunas D. R., Fortner J. G., Jaspan J., Sherwin R. S. Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab. 1986 Aug;63(2):439–446. doi: 10.1210/jcem-63-2-439. [DOI] [PubMed] [Google Scholar]
  5. Barnes A. J., Bloom A., Crowley M. F., Tuttlebee J. W., Bloom S. R., Alberti K. G., Smythe P., Turnell D. Is glucagon important in stable insulin-dependent diabetics? Lancet. 1975 Oct 18;2(7938):734–737. doi: 10.1016/s0140-6736(75)90722-9. [DOI] [PubMed] [Google Scholar]
  6. Barnes A. J., Bloom S. R., Goerge K., Alberti G. M., Smythe P., Alford F. P., Chisholm D. J. Ketoacidosis in pancreatectomized man. N Engl J Med. 1977 Jun 2;296(22):1250–1253. doi: 10.1056/NEJM197706022962202. [DOI] [PubMed] [Google Scholar]
  7. Bennett L. L. What causes fatty liver after pancreatectomy--an unresolved and forgotten controversy. The 1936-1954 years of controversy. Perspect Biol Med. 1983 Summer;26(4):595–612. doi: 10.1353/pbm.1983.0046. [DOI] [PubMed] [Google Scholar]
  8. Boden G., Master R. W., Rezvani I., Palmer J. P., Lobe T. E., Owen O. E. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. J Clin Invest. 1980 Mar;65(3):706–716. doi: 10.1172/JCI109717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Boosalis M. G., Evans G. W., McClain C. J. Impaired handling of orally administered zinc in pancreatic insufficiency. Am J Clin Nutr. 1983 Feb;37(2):268–271. doi: 10.1093/ajcn/37.2.268. [DOI] [PubMed] [Google Scholar]
  10. Braasch J. W., Deziel D. J., Rossi R. L., Watkins E., Jr, Winter P. F. Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg. 1986 Oct;204(4):411–418. doi: 10.1097/00000658-198610000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Braasch J. W., Vito L., Nugent F. W. Total pancreatectomy of end-stage chronic pancreatitis. Ann Surg. 1978 Sep;188(3):317–322. doi: 10.1097/00000658-197809000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brooks J. R., Brooks D. C., Levine J. D. Total pancreatectomy for ductal cell carcinoma of the pancreas. An update. Ann Surg. 1989 Apr;209(4):405–410. doi: 10.1097/00000658-198904000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. CAMERON J. R., SORENSON J. MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD. Science. 1963 Oct 11;142(3589):230–232. doi: 10.1126/science.142.3589.230. [DOI] [PubMed] [Google Scholar]
  14. CHERNICK S. S., SCOW R. O. Early effects of total pancreatectomy on fat metabolism in the rat. Am J Physiol. 1959 Jan;196(1):125–131. doi: 10.1152/ajplegacy.1958.196.1.125. [DOI] [PubMed] [Google Scholar]
  15. Catignani G. L., Bieri J. G. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem. 1983 Apr;29(4):708–712. [PubMed] [Google Scholar]
  16. Chang E. B., Bergenstal R. M., Field M. Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport. J Clin Invest. 1985 May;75(5):1666–1670. doi: 10.1172/JCI111874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chang E. B., Fedorak R. N., Field M. Experimental diabetic diarrhea in rats. Intestinal mucosal denervation hypersensitivity and treatment with clonidine. Gastroenterology. 1986 Sep;91(3):564–569. [PubMed] [Google Scholar]
  18. Collins J. J., Jr, Craighead J. E., Brooks J. R. Rationale for total pancreatectomy for carcinoma of the pancreatic head. N Engl J Med. 1966 Mar 17;274(11):599–602. doi: 10.1056/NEJM196603172741103. [DOI] [PubMed] [Google Scholar]
  19. Dabek J. T., Härkönen M., Wahlroos O., Adlercreutz H. Assay for plasma 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 by "high-performance" liquid chromatography. Clin Chem. 1981 Aug;27(8):1346–1351. [PubMed] [Google Scholar]
  20. De Leenheer A. P., De Bevere V. O., De Ruyter M. G., Claeys A. E. Simultaneous determination of retinol and alpha-tocopherol in human serum by high-performance liquid chromatography. J Chromatogr. 1979 Mar 1;162(3):408–413. doi: 10.1016/s0378-4347(00)81528-5. [DOI] [PubMed] [Google Scholar]
  21. Del Prato S., Tiengo A., Baccaglini U., Tremolada C., Duner E., Marescotti M. C., Avogaro A., Valverde I., Nosadini R., Assan R. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia. 1983 Sep;25(3):252–259. doi: 10.1007/BF00279939. [DOI] [PubMed] [Google Scholar]
  22. Dutta S. K., Bustin M. P., Russell R. M., Costa B. S. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med. 1982 Oct;97(4):549–552. doi: 10.7326/0003-4819-97-4-549. [DOI] [PubMed] [Google Scholar]
  23. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. J Clin Endocrinol Metab. 1987 Jul;65(1):30–36. doi: 10.1210/jcem-65-1-30. [DOI] [PubMed] [Google Scholar]
  24. FINLAY J. M., HOGARTH J., WIGHTMAN K. J. A CLINICAL EVALUATION OF THE D-XYLOSE TOLERANCE TEST. Ann Intern Med. 1964 Sep;61:411–422. doi: 10.7326/0003-4819-61-3-411. [DOI] [PubMed] [Google Scholar]
  25. Fortner J. G. "Radical" abdominal cancer surgery: current state and future course. Jpn J Surg. 1989 Sep;19(5):503–509. doi: 10.1007/BF02471655. [DOI] [PubMed] [Google Scholar]
  26. Fortner J. G., Kim D. K., Cubilla A., Turnbull A., Pahnke L. D., Shils M. E. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977 Jul;186(1):42–50. doi: 10.1097/00000658-197707000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Fortner J. G. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg. 1984 Apr;199(4):418–425. doi: 10.1097/00000658-198404000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Frey C. F., Child C. G., Fry W. Pancreatectomy for chronic pancreatitis. Ann Surg. 1976 Oct;184(4):403–413. doi: 10.1097/00000658-197610000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hall F. M., Davis M. A., Baran D. T. Bone mineral screening for osteoporosis. N Engl J Med. 1987 Jan 22;316(4):212–214. doi: 10.1056/NEJM198701223160410. [DOI] [PubMed] [Google Scholar]
  30. Horie H., Matsuyama T., Namba M., Itoh H., Nonaka K., Tarui S., Yamatodani A., Wada H. Responses of catecholamines and other counterregulatory hormones to insulin-induced hypoglycemia in totally pancreatectomized patients. J Clin Endocrinol Metab. 1984 Dec;59(6):1193–1196. doi: 10.1210/jcem-59-6-1193. [DOI] [PubMed] [Google Scholar]
  31. Ihse I., Lilja P., Arnesjö B., Bengmark S. Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg. 1977 Dec;186(6):675–680. doi: 10.1097/00000658-197712000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kiviluoto T., Schröder T., Karonen S. L., Kuusi T., Lempinen M., Taskinen M. R. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res. 1985;17(3):110–115. [PubMed] [Google Scholar]
  33. Kuku S. F., Zeidler A., Emmanouel D. S., Katz A. I., Rubenstein A. H. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes. J Clin Endocrinol Metab. 1976 Jan;42(1):173–176. doi: 10.1210/jcem-42-1-173. [DOI] [PubMed] [Google Scholar]
  34. Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes. 1977 Jan;26(1):22–29. doi: 10.2337/diab.26.1.22. [DOI] [PubMed] [Google Scholar]
  35. Levin B., ReMine W. H., Hermann R. E., Schein P. S., Cohn I., Jr Panel: cancer of the pancreas. Am J Surg. 1978 Feb;135(2):185–191. doi: 10.1016/0002-9610(78)90094-6. [DOI] [PubMed] [Google Scholar]
  36. Lowry S. F., Smith J. C., Jr, Brennan M. F. Zinc and copper replacement during total parenteral nutrition. Am J Clin Nutr. 1981 Sep;34(9):1853–1860. doi: 10.1093/ajcn/34.9.1853. [DOI] [PubMed] [Google Scholar]
  37. Meredith S. C., Rosenberg I. H. Gastrointestinal-hepatic disorders and osteomalacia. Clin Endocrinol Metab. 1980 Mar;9(1):131–150. doi: 10.1016/s0300-595x(80)80024-7. [DOI] [PubMed] [Google Scholar]
  38. Muller W. A., Berger M., Suter P., Cüppers H. J., Reiter J., Wyss T., Berchtold P., Schmidt F. H., Assal J. P., Renold A. E. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients. J Clin Invest. 1979 May;63(5):820–827. doi: 10.1172/JCI109381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Muller W. A., Brennan M. F., Tan M. H., Aoki T. T. Studies of glucagon secretion in pancreatectomized patients. Diabetes. 1974 Jun;23(6):512–516. doi: 10.2337/diab.23.6.512. [DOI] [PubMed] [Google Scholar]
  40. Müller W. A., Cüppers H. J., Zimmermann-Telschow H., Micheli H., Wyss T., Renold A. E., Berger M. Amino acids and lipoproteins in plasma of duodenopancreatectomized patients: effects of glucagon in physiological amounts. Eur J Clin Invest. 1983 Apr;13(2):141–149. doi: 10.1111/j.1365-2362.1983.tb00079.x. [DOI] [PubMed] [Google Scholar]
  41. Nosadini R., del Prato S., Tiengo A., Duner E., Toffolo G., Cobelli C., Faronato P. P., Moghetti P., Muggeo M. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 1982 Apr;31(4 Pt 1):346–355. doi: 10.2337/diab.31.4.346. [DOI] [PubMed] [Google Scholar]
  42. Peterson C. M., Jones R. L., Dupuis A., Levine B. S., Bernstein R., O'Shea M. Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. Diabetes Care. 1979 Jul-Aug;2(4):329–335. doi: 10.2337/diacare.2.4.329. [DOI] [PubMed] [Google Scholar]
  43. Pliam M. B., ReMine W. H. Further evaluation of total pancreatectomy. Arch Surg. 1975 May;110(5):506–512. doi: 10.1001/archsurg.1975.01360110052010. [DOI] [PubMed] [Google Scholar]
  44. Polonsky K. S., Herold K. C., Gilden J. L., Bergenstal R. M., Fang V. S., Moossa A. R., Jaspan J. B. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes. Diabetes. 1984 Nov;33(11):1112–1119. doi: 10.2337/diab.33.11.1112. [DOI] [PubMed] [Google Scholar]
  45. Priestley J. T., Comfort M. W., Radcliffe J. Total Pancreatectomy for Hyperinsulinism Due to an Islet-Cell Adenoma: Survival and Cure at Sixteen MOnths after Operation Presentation of Metabolic Studies. Ann Surg. 1944 Feb;119(2):211–221. doi: 10.1097/00000658-194402000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. ROSS D. E. Cancer of the pancreas; a plea for total pancreatectomy. Am J Surg. 1954 Jan;87(1):20–33. doi: 10.1016/0002-9610(54)90038-0. [DOI] [PubMed] [Google Scholar]
  47. ReMine W. H., Priestley J. T., Judd E. S., King J. N. Total pancreatectomy. Ann Surg. 1970 Oct;172(4):595–604. doi: 10.1097/00000658-197010000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Reynolds C., Molnar G. D., Horwitz D. L., Rubenstein A. H., Taylor W. F., Jiang N. S. Abnormalities of endogenous glucagon and insulin in unstable diabetes. Diabetes. 1977 Jan;26(1):36–45. doi: 10.2337/diab.26.1.36. [DOI] [PubMed] [Google Scholar]
  49. Sartoris D. J., Resnick D. New radiographic technique may renew credibility of bone densitometry. Mayo Clin Proc. 1988 Nov;63(11):1147–1150. doi: 10.1016/s0025-6196(12)65513-x. [DOI] [PubMed] [Google Scholar]
  50. Seeman E., Melton L. J., 3rd, O'Fallon W. M., Riggs B. L. Risk factors for spinal osteoporosis in men. Am J Med. 1983 Dec;75(6):977–983. doi: 10.1016/0002-9343(83)90878-1. [DOI] [PubMed] [Google Scholar]
  51. Shima K., Tanaka R., Morishita S., Tarui S., Kumahara Y. Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve. Diabetes. 1977 Aug;26(8):717–725. doi: 10.2337/diab.26.8.717. [DOI] [PubMed] [Google Scholar]
  52. Sönksen P. H., Judd S. L., Lowy C. Home monitoring of blood-glucose. Method for improving diabetic control. Lancet. 1978 Apr 8;1(8067):729–732. doi: 10.1016/s0140-6736(78)90854-1. [DOI] [PubMed] [Google Scholar]
  53. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979 Mar 15;300(11):573–578. doi: 10.1056/NEJM197903153001101. [DOI] [PubMed] [Google Scholar]
  54. Trede M., Schwall G. The complications of pancreatectomy. Ann Surg. 1988 Jan;207(1):39–47. doi: 10.1097/00000658-198801000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Trede M. The surgical treatment of pancreatic carcinoma. Surgery. 1985 Jan;97(1):28–35. [PubMed] [Google Scholar]
  56. Vernick L. J., Kuller L. H. Cholecystectomy and right-sided colon cancer: an epidemiological study. Lancet. 1981 Aug 22;2(8243):381–383. doi: 10.1016/s0140-6736(81)90830-8. [DOI] [PubMed] [Google Scholar]
  57. Yki-Järvinen H., Kiviluoto T., Taskinen M. R. Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism. 1986 Aug;35(8):718–727. doi: 10.1016/0026-0495(86)90239-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES